Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- University Hospital, Ghent
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Biochemical recurrence at follow-up
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
For primary surgical treatment of prostate cancer the investigators compare the classic open surgery (radical retropubic prostatectomy, RRP) versus robot-assisted laparoscopic surgery (RALP). Oncological results are obtained at standard follow-up consultations through Prostate-Specific Antigen (PSA) measurement to detect biochemical recurrence. Functional results (continence, potency, quality of life) are obtained through standardised questionnaires. Currently the investigators perform all of their prostatectomies in a robot-assisted manner. For results of the open surgery the investigators send questionnaires to patients who had the operation in the past.
Investigators
Eligibility Criteria
Inclusion Criteria
- •prostate cancer
- •radical retropubic prostatectomy or
- •robot-assisted laparoscopic surgery
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Biochemical recurrence at follow-up
Time Frame: 6 months after prostatectomy
PSA measurement in the serum should not be \> or = 0,20 ng/ml.
Biochemical recurrence at follow-up.
Time Frame: 6-monthly follow up between 1 and 5 years after prostatectomy.
PSA measurement in the serum should not be \> or = 0,20 ng/ml.
Secondary Outcomes
- Functional assessment concerning potency.(after 1, 3, 12 and 24 months)
- Functional assessment concerning continence.(after 1, 3, 12 and 24 months)
- Functional assessment concerning quality of life.(after 1, 3, 12 and 24 months)